CD112R相关论文
目前,针对抑制性受体或配体、PD-1/PD-L1及CTLA-4的靶向免疫治疗已经取得了显著的临床成果。然而,仍有许多患者未从免疫治疗中获益。......
Objective Gastric cancer is the second leading cause of cancer-related deaths and the fifth most common malignancy world......